What evidence is there on the cost of interventions to reach zero-dose children in LMICs? New scoping review in Vaccines

Home > What evidence is there on the cost of interventions to reach zero-dose children in LMICs? New scoping review in Vaccines

Researchers from Levin & Morgan, JSI, and Gavi, the Vaccine Alliance, have conducted a scoping review of studies that estimate the costs of increasing childhood vaccination and reducing prevalence of zero-dose children in low- and middle-income countries. Eleven studies met inclusion criteria, including 7 from South Africa, 3 from Africa and 1 from Latin America, with intervention costs varying from US$0.08 per additional dose for SMS reminders in Kenya to US$67 per dose for cash transfers in Nicaragua.

The wide variation in intervention costs underscores the need for standardized costing methodologies to enhance comparability across studies, and establishing research principles for costing zero-dose interventions could strengthen future evidence for policymaking.

  • LanguageEnglish

Submit your work

Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.